TCR2 THERAPEUTICS INC (TCRR)
US87808K1060 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -163.10M | -151.82M | -99.81M | -67.12M | -47.60M | |||
| Depreciation Amortization | 2.96M | 3.05M | 2.83M | 1.59M | 860.00K | |||
| Income Taxes - Deferred | -314.00K | -293.00K | 99.00K | 130.00K | N/A | |||
| Change In Working Capital | 12.14M | 9.58M | 1.62M | 870.00K | -1.10M | |||
| Other non cash items | 37.98M | 38.03M | 13.66M | 7.79M | 6.48M | |||
| OPERATING CASH FLOW | -110.34M | -101.46M | -81.60M | -56.74M | -41.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -13.63M | -15.45M | -11.45M | -7.16M | -3.88M | |||
| Other Investing Activity | 64.20M | -73.03M | 89.90M | -41.77M | -16.54M | |||
| INVESTING CASH FLOW | 50.57M | -88.49M | 78.45M | -48.94M | -20.42M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 175.00K | 256.00K | 132.55M | 134.76M | 79.52M | |||
| Other Financing Activity | -85.00K | -131.00K | -409.00K | -60.00K | 0.00 | |||
| FINANCING CASH FLOW | 90.00K | 125.00K | 132.14M | 134.70M | 79.52M | |||
| CHANGE IN CASH | -59.68M | -189.82M | 128.98M | 29.02M | 17.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -110.34M | -101.46M | -81.60M | -56.74M | -41.36M | |||
| Capital Expenditure | -13.63M | -15.45M | -11.45M | -7.16M | -3.88M | |||
| FREE CASH FLOW | -123.97M | -116.91M | -93.05M | -63.90M | -45.24M | |||
All data in USD